FDA product code GXO: Strip, Craniosynostosis, Preformed

GXO is the FDA product code for strip, craniosynostosis, preformed. It is a Class II device, regulated under 21 CFR 882.5900 and reviewed by the Neurology panel. FDA has cleared 2 510(k) submissions under GXO, from 2 different applicants. The average 510(k) review took 104 days (median 104).

Classification

FieldValue
Device nameStrip, Craniosynostosis, Preformed
Device classClass II
Regulation21 CFR 882.5900
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)
ImplantYes

Compare with all 510(k) review times · Search every GXO clearance

Top GXO applicants

ApplicantClearancesLatest
Codman & Shurtleff, Inc.12004-02-25
W. L. Gore & Associates, Inc.11996-07-31

Most recent GXO clearances

510(k)ApplicantDeviceDecision dateReview days
K033395Codman & Shurtleff, Inc.CODMAN DURAL GRAFT IMPLANT, MODELS 80-1471, 80-1472, 80-1473, 80-1474, 80-1475, 80-1476, 80-1477, 80-1478, 80-1480, 80-12004-02-25125
K961802W. L. Gore & Associates, Inc.PRECLUDE SYNBLOC MEMBRANE1996-07-3183

Recalls for GXO devices

openFDA lists no recalls for product code GXO.

Frequently asked questions

What is FDA product code GXO?

GXO is the FDA product code for strip, craniosynostosis, preformed. It is a Class II device, regulated under 21 CFR 882.5900 and reviewed by the Neurology panel.

What device class is GXO?

Class II, regulation 21 CFR 882.5900. Typical premarket route: 510(k).

How long does a 510(k) take for product code GXO?

Across 2 cleared submissions the average was 104 days from receipt to decision (median 104).

Which companies have the most GXO clearances?

Codman & Shurtleff, Inc. (1); W. L. Gore & Associates, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times